Overall rank by patents
#21,023
of 50,000 tracked assignees
USPTO PatentsView assignee record - 13 granted patents across 6 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
The verdict
According to USPTO PatentsView, D.o.r.c. ranks #21,023 of 50,000 tracked US assignees by granted-patent volume, with 13 patents across 6 technology areas.
USPTO PatentsView assignee plate
Corpus R21023 · Foreign Corporation #21,023 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Curbell Medical Products, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
D o r c Dutch Ophtha… · this assignee
29 score
3D Lighting Innovati… · lowest
7 score
What this shows D.o.r.c.'s Innovation Score is 29.3/100 (top 70% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
D.o.r.c. Dutch Ophthalmic Research Center (international) B.v. is a focused PatentsView assignee: 6 CPC subclasses with 92.3% of grants classified under A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2020. By volume, D.o.r.c. sits between Curbell Medical Products, Inc. and Dashamerica, Inc..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Curbell Medical Products, Inc.
13 patents
Currax Pharmaceuticals LLC
13 patents
Cyboenergy, Inc.
13 patents
Cytrellis Biosystems, Inc.
13 patents
D.T. Davis Enterprises, Ltd.
13 patents
DAIICHI SANKYO EUROPE GMBH
13 patents
DAJ GLOBAL PARTNERS LLC
13 patents
DASHAMERICA, INC.
13 patents
D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.
13 patents
What this shows D.o.r.c. holds 13 patents at rank #20,983, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #20,983 in granted patent volume.
Other assignees with the most granted patents in Dorc's primary technology class.
D.o.r.c.'s Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
29 Top 70% higher than 30% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 4 | 30.8% |
| 2020 | 1 | 7.7% |
| 2021 | 2 | 15.4% |
| 2022 | 1 | 7.7% |
| 2023 | 1 | 7.7% |
| 2024 | 4 | 30.8% |
Top 6 of 6 technology areas
Overall rank by patents
#21,023
of 50,000 tracked assignees
29.3 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.